
Vaccine Wars | The Hype Cycle | 2
Business Wars
00:00
Navigating the Highs and Lows of the mRNA Market
This chapter examines Moderna's challenges in the competitive mRNA market, emphasizing the impact of their IPO and subsequent stock price decline. It contrasts these difficulties with BioNTech's experience, showcasing the skepticism surrounding mRNA viability amid investor pressure for quick returns.
Transcript
Play full episode